rs138124318
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_006270.5(RRAS):c.362A>G(p.Lys121Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000224 in 1,614,084 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. K121K) has been classified as Likely benign.
Frequency
Consequence
NM_006270.5 missense
Scores
Clinical Significance
Conservation
Publications
- Noonan syndrome and Noonan-related syndromeInheritance: AD Classification: STRONG Submitted by: G2P
- Noonan syndromeInheritance: AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RRAS | NM_006270.5 | c.362A>G | p.Lys121Arg | missense_variant | Exon 4 of 6 | ENST00000246792.4 | NP_006261.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00109 AC: 166AN: 152162Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.000370 AC: 93AN: 251108 AF XY: 0.000287 show subpopulations
GnomAD4 exome AF: 0.000133 AC: 195AN: 1461804Hom.: 1 Cov.: 32 AF XY: 0.000117 AC XY: 85AN XY: 727218 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00109 AC: 166AN: 152280Hom.: 0 Cov.: 31 AF XY: 0.000927 AC XY: 69AN XY: 74466 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:2
Variant summary: RRAS c.362A>G (p.Lys121Arg) results in a conservative amino acid change located in the Small GTP-binding protein domain (IPR005225) of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00037 in 251108 control chromosomes, predominantly at a frequency of 0.0056 within the African or African-American subpopulation in the gnomAD database, including 1 homozygote. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 2240- fold the estimated maximal expected allele frequency for a pathogenic variant in RRAS causing Noonan Syndrome And Related Conditions phenotype (2.5e-06), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. To our knowledge, no occurrence of c.362A>G in individuals affected with Noonan Syndrome And Related Conditions and no experimental evidence demonstrating its impact on protein function have been reported. One other clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and cited the variant as likely benign. Based on the evidence outlined above, the variant was classified as benign. -
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Noonan syndrome Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at